Articles

Prostate Cancers are Primarily Forgettable

The Majority of Prostate Cancers Behave as Non-Cancerous: Most prostate cancers such as the common Gleason 6 prostate “cancer”, even though labelled as a cancer, behave as non-cancerous. The Gleason 6 prostate “cancer” – > does not cause death > is labelled a “cancer” based purely on low-power microscopic appearances > unlike a typical cancer cell, lacks […]

Continue Reading →

Posted in: Prostate Cancer News, Womens Health

Leave a Comment (0) →

The BOGUS Gleason 6 prostate cancer (and most everything else about prostate cancer)

Press Release: CORAL SPRINGS, Fla., Sept. 22, 2016 /PRNewswire/ — Noted urologic surgeon, Bert  Vorstman MD, MS, FAAP, FRACS, FACS today, has issued a stinging report regarding the unreliable PSA test, the mislabelling of the common Gleason 6 prostate disease as a cancer and, the misrepresentation that the radical (robotic) prostatectomy treatment is scientifically proven to […]

Continue Reading →

Posted in: Uncategorized

Leave a Comment (0) →

the PROSTATE EXAM or DRE

the PROSTATE EXAM or DRE Bert Vorstman MD, MS, FAAP, FRACS, FACS The prostate exam, also known as the DRE (digital rectal exam), is considered a normal part of a man’s physical examination. However, aside from this DRE prostate exam being considered “standard” by physicians and, expected by men as part of their testing, the […]

Continue Reading →

Posted in: Mens Health, Prostate Cancer News

Leave a Comment (0) →

Testing Aggressiveness of Prostate Cancer Improves Quality of Life, Study Finds

Researchers working with the Fred Hutchinson Cancer Research Center have found that the Metamark Promark prostate cancer test increases the quality-­adjusted life­-years and decreases healthcare costs for patients who are being screened for prostate cancer. In a paper published in October 2015 in T he Oncologist, the researchers showcased their findings. According to the study, […]

Continue Reading →

Posted in: Mens Health, Prostate Cancer News

Leave a Comment (0) →

Focused Ultrasound System Receives Go Ahead for Prostate Cancer Ablation

On October 9, 2015, the Sonablate 450, a high intensity focused ultrasound (HIFU) system for treating prostate cancer, received FDA approval. The Sonablate uses high intensity therapeutic ultrasound to heat and destroy the prostate cancer without damaging surrounding tissue. The Sonablate allows doctors to carefully target the diseased tissue within the prostate, heating and destroying […]

Continue Reading →

Posted in: Prostate Cancer News

Leave a Comment (0) →
Page 1 of 10 12345...»